Zenotech Laboratories Limited

BSE:532039 Stock Report

Market Cap: ₹4.3b

Zenotech Laboratories Past Earnings Performance

Past criteria checks 2/6

Zenotech Laboratories has been growing earnings at an average annual rate of 10.5%, while the Biotechs industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 13.4% per year. Zenotech Laboratories's return on equity is 7.1%, and it has net margins of 18.5%.

Key information

10.5%

Earnings growth rate

10.7%

EPS growth rate

Biotechs Industry Growth5.1%
Revenue growth rate13.4%
Return on equity7.1%
Net Margin18.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Zenotech Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:532039 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24360671100
30 Jun 24386811020
31 Mar 2436883950
31 Dec 23391113890
30 Sep 2336893850
30 Jun 2336193820
31 Mar 23390116790
31 Dec 22370220770
30 Sep 22383243750
30 Jun 22356225730
31 Mar 22329222710
31 Dec 2131992700
30 Sep 2127357690
30 Jun 2123327670
31 Mar 21194-12650
31 Dec 20178-24600
30 Sep 2019744610
30 Jun 2023985600
31 Mar 20259108580
31 Dec 19253134580
30 Sep 1922456540
30 Jun 1917912510
31 Mar 19130-31500
31 Dec 18111-73490
30 Sep 18109-78510
30 Jun 18107-91510
31 Mar 18111-119510
31 Dec 17101-143490
30 Sep 1770-181430
30 Jun 1747-196350
31 Mar 1723-199310
31 Dec 166-202150
30 Sep 167-197220
30 Jun 1615-195340
31 Mar 1621-191230
31 Dec 1528-24920
30 Sep 1531-313260
30 Jun 1533-308260
31 Mar 1541-201330
31 Mar 1428-2716215

Quality Earnings: 532039 has high quality earnings.

Growing Profit Margin: 532039's current net profit margins (18.5%) are lower than last year (25.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 532039 has become profitable over the past 5 years, growing earnings by 10.5% per year.

Accelerating Growth: 532039's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 532039 had negative earnings growth (-28.6%) over the past year, making it difficult to compare to the Biotechs industry average (7.1%).


Return on Equity

High ROE: 532039's Return on Equity (7.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 16:01
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zenotech Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution